[1] |
Barnabas RV, Laukkanen P, Koskela P, et al. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses[J]. PLoS Medicine, 2006, 3(5): e138. doi: 10.1371/journal.pmed.0030138
|
[2] |
王玉, 陈姗姗, 傅新楚. 传播动力学模型回顾与展望[J]. 应用数学与计算数学学报, 2018, 32(2): 267 – 294. doi: 10.3969/j.issn.1006-6330.2018.02.008
|
[3] |
Dasbach EJ, Elbasha EH, Insinga RP. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease[J]. Epidemio-logic Reviews, 2006, 28(1): 88 – 100. doi: 10.1093/epirev/mxj006
|
[4] |
郄素会. 宫颈癌疫苗用于18~25岁中国女性预防宫颈癌的药物经济学评价[J]. 临床医药文献电子杂志, 2017, 4(48): 9342 – 9343, 9345. doi: 10.3877/j.issn.2095-8242.2017.48.025
|
[5] |
张倩. 子宫颈癌筛查的风险分流及疫苗的卫生经济学评价研究[D]. 北京: 北京协和医学院, 2017.
|
[6] |
孙雨欣, 刘永军, 刘通. 宫颈癌疫苗用于18~25岁中国女性预防宫颈癌的药物经济学评价[J]. 中国循证医学杂志, 2017, 17(1): 102 – 107. doi: 10.7507/1672-2531.201610004
|
[7] |
莫秀婷. 我国宫颈癌预防策略的经济学评价[D]. 济南: 山东大学, 2015.
|
[8] |
刘怡君. HPV-16/18预防性疫苗的接种年龄对其预防子宫颈癌作用的卫生经济学研究[D]. 大连: 大连医科大学, 2015.
|
[9] |
宋晓彬, 赵勤俭, 周鼒, 等. 二价HPV疫苗接种策略的卫生经济学评估: 基于动态模型[J]. 中华预防医学杂志, 2017, 51(9): 814 – 820. doi: 10.3760/cma.j.issn.0253-9624.2017.09.008
|
[10] |
Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies[J]. Emerging Infectious Disease, 2007, 13(1): 28 – 41. doi: 10.3201/eid1301.060438
|
[11] |
Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics: V. Analysis of experimental epidemics of mouse-typhoid; a bacterial disease conferring incomplete immu-nity[J]. Epidemiology and Infection, 1939, 39(3): 271 – 288.
|
[12] |
Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics-II. The problem of endemicity[J]. Bulletin of Mathematical Biology, 1991, 53(1): 57 – 87.
|
[13] |
Wolff E, Elfström KM, Haugen Cange H, et al. Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour[J]. Vaccine, 2018, 36(34): 5160 – 5165. doi: 10.1016/j.vaccine.2018.07.018
|
[14] |
Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination Programmes[J]. PharmacoEconomics, 2008, 26(3): 191 – 215. doi: 10.2165/00019053-200826030-00004
|
[15] |
Canfell K, Chesson H, Kulasingam SL, et al. Modeling preventative strategies against human papillomavirus-related disease in developed countries[J]. Vaccine, 2012, 30 Suppl 5: F157 – F167.
|
[16] |
Tay SK, Hsu TY, Pavelyev A, et al. Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis[J]. BJOG: An International Journal of Obstetrics and Gynaecology, 2018, 125(4): 478 – 486. doi: 10.1111/1471-0528.15106
|
[17] |
Damm O, Horn J, Mikolajczyk RT, et al. Cost-effectiveness of human papillomavirus vaccination in Germany[J]. Cost Effective-ness and Resource Allocation, 2017, 15: 18. doi: 10.1186/s12962-017-0080-9
|
[18] |
Largeron N, Petry KU, Jacob J, et al. An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany[J]. Expert Review of Pharmacoe-conomics and Outcomes Research, 2017, 17(1): 85 – 98. doi: 10.1080/14737167.2016.1208087
|
[19] |
Mennini FS, Bonanni P, Bianic F, et al. Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy[J]. Cost Effectiveness and Resource Allocation, 2017, 15(1): 11. doi: 10.1186/s12962-017-0073-8
|
[20] |
Tang CH, Cheng WF, Jiang JH, et al. Cost-effectiveness analysis of human papillomavirus vaccination in adolescent girls in Taiwan[J]. Asian Pacific Journal of Cancer Prevention, 2019, 20(5): 1377 – 1387. doi: 10.31557/APJCP.2019.20.5.1377
|
[21] |
张师前, 王凯, 张远丽. HPV疫苗在中国的应用现状[J]. 中国实用妇科与产科杂志, 2019, 35(10): 1090 – 1095.
|
[22] |
国家药品监督管理局. 首个国产重组人乳头瘤病毒疫苗获批上市[EB/OL]. [2020 – 01 – 03]. http://www.nmpa.gov.cn/WS04/CL2056/373049.html.
|
[23] |
Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5[J]. Value in Health, 2012, 15(6): 828 – 834. doi: 10.1016/j.jval.2012.06.011
|